Histological and chemical examinations of biopsy specimens from cerebral tissue of children suffering from undiagnosed progressive brain disease are performed increasingly. Important information is provided, which, though rarely of therapeutic value, does increase precision of diagnosis, prognosis, and genetic advice (Cumings, 1965a, b, c; Poser, 1962; Adams, 1965) . This is especially true of the chemical investigations, and it is likely that chernical analyses will challenge the current classifications of progressive brain disease. Amaurotic idiocy has already proved to be more heterogeneous than was thought hitherto, while supposedly different diseases, such as Niemann-Pick's and gargoylism, have more in common than earlier classifications suggested.
However, brain biopsy is still a procedure not to be undertaken lightly, and it would be an advantage if comparable information could be gained by a less drastic method. We have been interested in the possibility of finding abnormalities in easily 'accessible tissue, such as red blood cells, which might correlate with abnormalities in the constitution of the brain. In this paper we give the results of a study of the sphingomyelin content of erythrocytes in children with various types of progressive brain disease.
Material and Methods
The patients included in this study are enumerated in the legend to the Fig. Nearly all were more than 2 years old. The group of children with juvenile amaurotic idiocy came from different hospitals; in only some of these cases was the diagnosis verified by histological and biochemical investigation of brain tissue. All the other patients were under our care, the diagnosis being verified in nearly all by means of biopsies.
The 10 patients with progressive brain disease (dementia and neurological abnormalities), in which Received August 26, 1968. no diagnosis could be made, are briefly described in Table I . Incomplete investigation made it impossible to reach a diagnosis in Cases 7 and 8. The molar concentrations of phospholipids in the red blood cells have been determined as described by Hooghwinkel and Niekerk (1960) , Hooghwinkel and Borri (1964) , and Hooghwinkel, Borri, and Bruyn (1966) . The amounts of the various phospholipids of red blood cells have been expressed as molar percentages of total phospholipids. Absolute values of phospholipids depend a good deal on size and shape of the red blood cells, and they vary with changes in the ratio of total cell surface to the total cell volume; this ratio itself may be influenced by the lipid composition of the membrane. Thus, it is more likely that a metabolic disturbance will manifest itself in a change in the percentage distribution of the various phospholipids.
Patients with dementia of unknown origin. The patients in this group either showed normal development before the illness or had shown slow development from birth. In all, however, there was a clear-cut intellectual deterioration, together usually with epileptic symptoms and other neurological symptoms. Before a biopsy was done, extensive investigations were undertaken, of blood, urine, and CSF (including electrophoresis and cytology). Urinary excretion of amino acids and mucopolysaccharides was always checked. In most cases the urine was investigated for metachromatic material and/or arylsulphatase-A. Pyridoxine deficiency and dependency were excluded. White blood cells and cells in CSF were examined for abnormal granules and vacuoles. EEG's were made repeatedly (Dr. K. Mechelse). Biopsy of rectal mucosa or sural nerve was made in a few cases. It was often difficult to make a histological diagnosis from these specimens, and, at least in our laboratories, impossible to analyse biochemically such small amounts of tissue.
If a progressive cerebral disease were present, and no diagnosis could be arrived at using the abovementioned methods, brain biopsy was planned. With permission from the parents, a biopsy was taken from the prefrontal lobe by means of a small craniotomy. The specimens were investigated both histologically and biochemically. In two cases biopsy was refused by the parents. In one case the biopsy was postponed, because of intercurrent illness. If visceral involvement was suspected we preferred to take a biopsy from the liver. In Table I we summarize the relevant data of the 10 patients in this group of dementia of unknown origin. Table II summarizes the results of the phospholipid determinations, and the Figure shows the distribution of the molar percentages of sphingomyelin in the red blood cells. In general the sphingomyelin content of plasma showed the same trend as that of red blood cells, but less consistently. Sphingomyelin percentages were abnormally low in many cases. The patients suffering from amaurotic idiocy were exceptional, in that in all these cases sphingomyelin values were within normal limits. The control group, consisting of patients with severe cerebral atrophy after brain damage, usually due to a purulent meningitis many years earlier, also showed normal values. The one case of metachromatic leucodystrophy also had normal sphingomyelin in red cells; we do not know yet if this is typical for this disease. The group of dementias of unknown origin showed low sphingomyelin values in all cases but one. Discussion A low sphingomyelin content of red blood cells is perhaps explicable in those patients whose disease is associated with accumulation of sphingolipids in the central nervous system and/or other tissues. This is the case both in Hurler's disease (Ledeen et al., 1965; Borri, Hooghwinkel, and Edgar, 1966) and in Tay-Sachs's disease (Svennerholm, 1962) where gangliosides are stored in the brain; in Gaucher's disease (Rosenberg and Chargaff, 1958; Janse and Hooghwinkel, 1967) where cerebrosides are accumulating in liver and spleen; and in Niemann-Pick's disease where there is accumulation of sphingomyelin (Hooghwinkel and Borri, 1964) . Lowered sphingomyelin concentration of red blood cells might also have been expected in metachromatic leucodystrophy, where sulphatides are accumulating in the brain (Austin, 1965 Figure are all examples of disorders of lipid storage, the sphingolipids accumulating in the central nervous system and/or the visceral organs. The red cells of these patients showed a decrease in sphingomyelin in nearly every case. The fact that the group of 10 patients in whom no diagnosis could be made showed a similar decrease of sphingomyelin content of red blood cells suggests that in these patients also there was some abnormality of lipid metabolism.
Results
The change in sphingomyelin content of red blood cells may be indicative of a more generalized disturbance of sphingolipid metabolism. It is known that accumulation of various sphingolipids is caused by absence or deficiency of katabolic enzymes. In Gaucher's disease there is a deficiency of cerebrosidase (Brady, Kanfer, and Shapiro, 1965) ; in Niemann-Pick's disease a deficiency of sphingomyelinase (Brady et al., 1966) , and in metachromatic leucodystrophy a deficiency of arylsulphatase (Mehl and Jatzkewitz, 1965 A further group of 10 children with progressive brain disease was studied, in whom no exact diagnosis could be made, despite extensive investigation which often included brain or liver biopsy. In 9 of these 10 patients, red blood cell sphingomyelin content was decreased, suggesting an abnormality of sphingolipid metabolism.
Estimation of red blood cell sphingomyelin. content should precede more drastic investigations such as brain biopsy, as it may provide an important approach to the diagnosis ofbrain disease in children.
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